North Star Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
1,978
-209
-10% -$27.5K 0.01% 329
2026
Q1
$305K Buy
2,187
+20
+0.9% +$2.8K 0.01% 294
2025
Q4
$266K Sell
2,167
-6
-0.3% -$729 0.01% 298
2025
Q3
$241K Buy
2,173
+1
+0% +$114 0.01% 307
2025
Q2
$241K Hold
2,172
0.01% 302
2025
Q1
$243K Hold
2,172
0.01% 275
2024
Q4
$201K Buy
+2,172
New +$196K 0.01% 306
2021
Q4
Sell
-3,322
Closed -$232K 320
2021
Q3
$232K Sell
3,322
-258
-7% -$18.1K 0.01% 283
2021
Q2
$247K Sell
3,580
-775
-18% -$51.7K 0.01% 279
2021
Q1
$281K Buy
+4,355
New +$281K 0.02% 241
2016
Q3
Sell
-3,651
Closed -$305K 244
2016
Q2
$305K Hold
3,651
0.04% 194
2016
Q1
$335K Buy
3,651
+431
+13% +$38.9K 0.04% 190
2015
Q4
$326K Hold
3,220
0.04% 195
2015
Q3
$316K Buy
3,220
+1
+0% +$111 0.04% 195
2015
Q2
$377K Buy
3,219
+100
+3% +$10.9K 0.04% 201
2015
Q1
$306K Hold
3,119
0.03% 202
2014
Q4
$294K Hold
3,119
0.03% 205
2014
Q3
$332K Sell
3,119
-500
-14% -$49K 0.04% 199
2014
Q2
$300K Sell
3,619
-200
-5% -$15.6K 0.04% 207
2014
Q1
$271K Sell
3,819
-1,000
-21% -$78.4K 0.03% 214
2013
Q4
$362K Hold
4,819
0.04% 187
2013
Q3
$303K Buy
4,819
+619
+15% +$37K 0.04% 198
2013
Q2
$215K Buy
+4,200
New +$219K 0.03% 220

Other funds holding GILD

North Star Asset Management's GILD Position: Q2 2026 in Review

North Star Asset Management reduced its Gilead Sciences (GILD) stake by 9.6% in Q2 2026, selling an estimated $27.5K and leaving 1,978 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #329.

North Star Asset Management first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $377K in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • North Star Asset Management held 1,978 shares of Gilead Sciences worth $250K as of Q2 2026.
  • North Star Asset Management sold 209 Gilead Sciences shares in Q2 2026, an estimated $27.5K.
  • Gilead Sciences made up 0.01% of North Star Asset Management's portfolio in Q2 2026, its #329 holding.
  • North Star Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • North Star Asset Management's Gilead Sciences position peaked at $377K in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.